Investor Information
As of March 31, 2024
Stock listing | Tokyo Stock Exchange(Prime Ticker Code:7600) |
---|---|
Transfer agent | Sumitomo Mitsui Trust Bank, Limited |
Common stock | authorized: 37,728,000 shares issued: 26,475,880 shares |
Number of stockholders | 6,304 |
Status of major shareholders
Name of Shareholders | Number of shares held (shares) |
Percentage of shares held (%) |
---|---|---|
Mitsui Chemicals, Inc. | 7,942,764 | 30.01 |
Custody Bank of Japan, T. | 1,787,959 | 6.75 |
Master Trust Bank of Japan, T. | 1,779,200 | 6.27 |
Takashi Watanabe | 1,168,800 | 4.41 |
MSIP CLIENT SECURITIES | 1,083,200 | 4.09 |
Yasuo Watanabe | 1,012,064 | 3.82 |
Motohiro Shimazaki | 893,302 | 3.37 |
CACEIS BANK , LUXEMBOURG BRANCH UCITS CLIENTS ASEETS |
587,800 | 2.22 |
Hiroshi Kusakabe | 390,529 | 1.47 |
BNYM SA/NV FOR BNY M FOR BNYM GCM CLIENT ACCTS M ILM FE | 228,303 | 0.86 |
※1: Shareholding ratios are rounded down to the third decimal place.
※2: The above list excludes Japan Medical Dynamic Marketing’s treasury stock of 15,559 shares. Each shareholding ratio is calculated excluding treasury stock.Additionally, the number of treasury stock does not include the 125,759 shares of the Company’s stock held by stock transfer profits for officers.
Dividend Information
Dividend policy
Our basic policy on shareholder returns (dividends) is to pay stable dividends and to flexibly return profits to shareholders by comprehensively taking into account the balance between business performance and investment in growth areas.
Dividend
Year | Cash dividends |
---|---|
2024 | ¥14.0 |
2023 | ¥13.0 |
2022 | ¥12.0 |
2021 | ¥11.0 |
2020 | ¥10.0 |